COVID-19: Serum Institute's Novavax vaccine shows 90% overall efficacy

Credit: DNA- Published on June 15, 2021
Novavax in collaboration with Indian drug manufacturer Serum Institute of India is manufacturing these vaccines for India and low-income countries.

Video credit: Oneindia
Published on June 17, 2021 -  01:47
Covid19: Serum Institute of India to start trials of Novavax vaccine for kids in July| Oneindia News
The Serum Institute of India (SII) hopes to start the clinical trials of Novavax's Covid-19 vaccine 'Covovax' on children in July. The SII is also planning to introduce 'Covovax' its version of the US firm Novavax's vaccine candidate in India by September. Last year in September, Novavax had announced a manufacturing agreement with SII for its Covid-19 vaccine. #Novavax #ClinicalTrialsInKids #Covid19

You are here


💡 newsR Knowledge: Other News Mentions

COVID-19

Disease caused by severe acute respiratory syndrome coronavirus 2
The Union health ministry on Wednesday clarified that while some Covid-19 cases could go undetected as per the principles of infectious disease and its..
Credit: IndiaTimes - Published 56 minutes ago




Related videos from verified sources

Serum Institute begins production of Novavax | 50 cases of Delta Plus in India | Oneindia News 03:02
Credit: Oneindia - Published on June 25, 2021 


You might like